Mouse Models of Frontotemporal Dementia

被引:69
|
作者
Roberson, Erik D. [1 ,2 ]
机构
[1] Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Neurobiol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL USA
关键词
AMYOTROPHIC-LATERAL-SCLEROSIS; INCLUSION-BODY MYOPATHY; TRANSGENIC MICE; LOBAR DEGENERATION; PAGET-DISEASE; HEXANUCLEOTIDE REPEAT; BEHAVIORAL VARIANT; TDP-43; EXPRESSION; TARDBP MUTATIONS; MOTOR-NEURONS;
D O I
10.1002/ana.23722
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The pace of discovery in frontotemporal dementia (FTD) has accelerated dramatically with the discovery of new genetic causes and pathological substrates of the disease. MAPT/tau, GRN/progranulin, and C9ORF72 have emerged as common FTD genes, and TARDBP/TDP-43, VCP, FUS, and CHMP2B have been identified as less common genetic causes. TDP-43 and FUS have joined tau as common neuropathological substrates of the disease. Mouse models provide an important tool for understanding the role of these molecules in FTD pathogenesis. Here, we review recent progress with mouse models based on tau, TDP-43, progranulin, VCP, and CHMP2B. We also consider future prospects for FTD models, including developing new models to address unanswered questions. There are also opportunities for capitalizing on conservation of the salience network, which is selectively vulnerable in FTD, and the availability of FTD-related behavioral paradigms to analyze mouse models of the disease. ANN NEUROL 2012;72:837-849
引用
收藏
页码:837 / 849
页数:13
相关论文
共 50 条
  • [1] Mouse models of frontotemporal dementia: A comparison of phenotypes with clinical symptomatology
    Ahmed, Rebekah M.
    Irish, Muireann
    van Eersel, Janet
    Ittner, Arne
    Ke, Yazi D.
    Volkerling, Alexander
    van der Hoven, Julia
    Tanaka, Kimi
    Karl, Tim
    Kassiou, Michael
    Kril, Jillian J.
    Piguet, Olivier
    Gotz, Jurgen
    Kiernan, Matthew C.
    Halliday, Glenda M.
    Hodges, John R.
    Ittner, Lars M.
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2017, 74 : 126 - 138
  • [2] Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations
    Kashyap, Shreya N.
    Boyle, Nicholas R.
    Roberson, Erik D.
    NEUROTHERAPEUTICS, 2023, 20 (01) : 140 - 153
  • [3] Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations
    Shreya N. Kashyap
    Nicholas R. Boyle
    Erik D. Roberson
    Neurotherapeutics, 2023, 20 (1) : 140 - 153
  • [4] Taste processing in a mouse model of frontotemporal dementia
    Zheng, Yuejiao
    Blackwell, Jennifer
    Fontanini, Alfredo
    CHEMICAL SENSES, 2023, 48
  • [5] Taste Processing in a Mouse Model of Frontotemporal Dementia
    Zheng, Yuejiao
    Blackwell, Jennifer
    Fontanini, Alfredo
    NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 73 - 73
  • [6] Evaluating Behavior in Mouse Models of the Behavioral Variant of Frontotemporal Dementia: Which Test for Which Symptom?
    Vernay, Aurelia
    Sellal, Francois
    Rene, Frederique
    NEURODEGENERATIVE DISEASES, 2016, 16 (3-4) : 127 - 139
  • [7] Apathy-like behaviour in tau mouse models of Alzheimer's disease and frontotemporal dementia
    Robinson, Lianne
    Dreesen, Eline
    Mondesir, Miguel
    Harrington, Charles
    Wischik, Claude
    Riedel, Gernot
    BEHAVIOURAL BRAIN RESEARCH, 2024, 456
  • [8] Animal models of Alzheimer's disease and frontotemporal dementia
    Jürgen Götz
    Lars M. Ittner
    Nature Reviews Neuroscience, 2008, 9 : 532 - 544
  • [9] Animal models of Alzheimer's disease and frontotemporal dementia
    Gotz, Jurgen
    Ittner, Lars M.
    NATURE REVIEWS NEUROSCIENCE, 2008, 9 (07) : 532 - 544
  • [10] Induced pluripotent stem cell models of frontotemporal dementia
    Preza, E.
    Hardy, J.
    Warner, T.
    Wray, S.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2016, 42 (06) : 497 - 520